5472-26-4 Usage
Uses
Used in Pharmaceutical Industry:
(16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)acetic acid (non-preferred name) is used as a potential pharmaceutical agent for its involvement in biochemical processes. Its specific molecular structure and interactions may offer unique properties for the development of new drugs and therapies.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (16,18-dioxo-17-azapentacyclo[6.6.5.0~2,7~.0~9,14~.0~15,19~]nonadeca-2,4,6,9,11,13-hexaen-17-yl)acetic acid (non-preferred name) serves as a subject of study for understanding its properties and exploring its potential applications. Further research and analysis are necessary to fully harness its capabilities in drug discovery and development.
Check Digit Verification of cas no
The CAS Registry Mumber 5472-26-4 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,7 and 2 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5472-26:
(6*5)+(5*4)+(4*7)+(3*2)+(2*2)+(1*6)=94
94 % 10 = 4
So 5472-26-4 is a valid CAS Registry Number.
5472-26-4Relevant articles and documents
Synthesis, anti-inflammatory and analgesic evaluation of certain new 3a,4,9,9a-tetrahydro-4,9-benzenobenz[f]isoindole-1,3-diones
Abu-Hashem,Gouda
scheme or table, p. 543 - 551 (2011/10/19)
In an effort to establish new candidates with improved analgesic and anti-inflammatory activities, we reported here the synthesis and in-vivo analgesic and anti-inflammatory evaluation of various series of 2-substituted-3a,4,9,9a-tetrahydro-4,9-benzeno-be
Modular Design of Hosts Involving a Rigid Succinimide Framework and N-Bonded Lateral Groups. Crystalline Inclusion Properties and Crystal Structures of Inclusion Compounds with Dioxane, MeOH, and DMF
Weber, Edwin,Finge, Stephan,Csoeregh, Ingeborg
, p. 7281 - 7288 (2007/10/02)
A series of crystalline host molecules comprising a characteristic 9,10-dihydro-9,10-ethanoanthracene-11,12-dicarboxamide framework have been synthesized and studied with regard to their inclusion behavior.They follow a new design concept which is to conv